CH Biotech R&D Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 671.516 million compared to TWD 564.114 million a year ago. Operating income was TWD 322.206 million compared to TWD 248.188 million a year ago. Net income was TWD 248.121 million compared to TWD 178.671 million a year ago. Basic earnings per share from continuing operations was TWD 2.94 compared to TWD 2.12 a year ago. Diluted earnings per share from continuing operations was TWD 2.91 compared to TWD 2.1 a year ago.